A major discovery in cancer investigation is emerging with the use of nanobodies to reactivate damaged p53. This crucial malignant protector protein is frequently inactivated in several types of malignancies, resulting https://pr6bookmark.com/story22156641/vhh-fragments-reactivate-tumor-suppressor-p53-a-potential-pathway-for-cancer-management